Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2400 Neoplasms 1819 Carcinoma, Non-Small-Cell Lung 1599 Prostatic Neoplasms 1298 Colorectal Neoplasms 1140 Lung Neoplasms 984 Neoplasm Metastasis 830 Multiple Myeloma 792 Leukemia, Myeloid, Acute 767 Ovarian Neoplasms 674 Pancreatic Neoplasms 662 Melanoma 660 Squamous Cell Carcinoma of Head and Neck 586 Carcinoma, Hepatocellular 567 Recurrence 562 Brain Neoplasms 527 Glioblastoma 513 Head and Neck Neoplasms 500 Stomach Neoplasms 497 Triple Negative Breast Neoplasms 465 Lymphoma 454 Uterine Cervical Neoplasms 450 Carcinoma, Renal Cell 425 Precursor Cell Lymphoblastic Leukemia-Lymphoma 410 Lymphoma, Non-Hodgkin 389 Endometrial Neoplasms 381 Sarcoma 368 Lymphoma, Follicular 356 Urinary Bladder Neoplasms 354 Hematologic Neoplasms 352

Interventions

ivosidenib 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × AML × 1 year × Clear all

NCT06717958 2025-07-02

PIVOT

Technische Universität Dresden

Phase 2 Recruiting

AML

Data powered by HemOnc (CC BY 4.0) Colophon ⚡